A faster, better way to market
Evotec`s INDiGO accelerates early drug candidates into the clinic by reducing time from nomination to regulatory submission in 52 weeks, and under circumstances, even less. We achieve accelerated development by tightly integrating traditional drug silos into a single project managed under one roof.
The programme has been proven to reduce time and cost while achieving a quality data package for CTA/IND level regulatory filings.
Evotec`s INDiGO projects are managed by our most experienced, dedicated project managers and leading world-class drug development professionals implementing tailored development strategies designed specifically for the molecule, therapeutic area and strategic needs. The project plan is designed to integrate development areas: API Manufacture, Formulation Development, Clinical Supply, Safety Assessment, DMPK, Bioanalysis Studies and Regulatory Submission Documents Preparation.
Key features of Evotec`s INDiGO are:
- Each INDiGO programme is custom-designed for each molecule, taking into account all development factors including the type of molecule, dosage form and therapeutic area. Solutions are available for all therapeutic areas, small and large molecules, drug product changes post-FIM & IP extension opportunities
- The project will be managed by Evotec in collaboration with you according to an agreed-upon project plan, timeline and budget with agreed decision points identified throughout the course of the project